Abstract
Biobanking of human tissues is associated with a range of ethical, legal, and social (ELS) challenges. These include difficulties in operationalising informed consent protocols, protecting donors’ privacy, managing the return of incidental findings, conceptualising ownership of tissues, and benefit sharing. Though largely unresolved, these challenges are well documented and debated in academic literature. One common response to the ELS challenges of biobanks is a call for strong and independent governance of biobanks. Theorists who argue along these lines suggest that since fully informed consent to a single research project is often not feasible, research participants should be given the additional protection of being allowed to consent to the governance framework of the biobank. Such governance therefore needs to be transparent and ethically sustainable. In this paper we review the governance challenges of establishing and maintaining human tissue biobanks. We then discuss how the creation of a biobank for eggs and embryos, in particular, may introduce additional or unique challenges beyond those presented by the biobanking of other human tissues. Following previous work on biobank governance, we argue that ethically sustainable governance needs to be participatory, adaptive, and trustworthy.
Similar content being viewed by others
Notes
Some versions of open consent may also involve participants agreeing to any uses within a stated scope of research.
We note here recent advances that allow genetic material from more than `two individuals to be used in the creation of embryos.
The fourth principle of ‘fit’ outlined by O’Doherty et al. (2011) is implicit in this discussion, since it pertains to consideration of a specific type of biobank.
However, as outlined above, Canadian regulations may prohibit this.
References
Anderlik, M.R. 2003. Commercial biobanks and genetic research: ethical and legal issues. American Journal of Pharmacogenomics 3: 203–215.
Assisted Human Reproduction Act. 2004. Retrieved from the Government of Canada Justice Laws website http://laws-lois.justice.gc.ca/eng/acts/A-13.4/.
Bjorn, G. 2008. Barriers set up to protect genome databases. Nature Medicine 14: 996.
Budimir, D., O. Polasek, A. Marusic, I. Kolcic, T. Zemunik, V. Boraska, A. Jeroncic, M. Boban, H. Campbell, and I. Rudan. 2011. Ethical aspects of human biobanks: A systematic review. Croatian Medical Journal 52(3): 262–279.
Burgess, M., K. O’Doherty, and D. Secko. 2008. Biobanking in British Columbia: discussions of the future of personalized medicine through deliberative public engagement. Personalized Medicine 5(3): 285–296.
Cambon-Thomsen, A., E. Rial-Sebbag, and B.M. Knoppers. 2007. Trends in ethical and legal frameworks for the use of human biobanks. European Respiratory Journal 30: 373–382.
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. 2010.
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. December 2014.
Capron, A.M., A. Mauron, B.S. Elger, A. Ganguli-Mitra, and N. Biller-Andorno. 2009. Ethical norms and the international governance of genetic databases and biobanks: Findings from an international study. Kennedy Institute of Ethics Journal 19(2): 101–124.
Caulfield, T. 2014. Who owns your tissue? You’d be Surprised. Canada: The Globe and Mail.
Caulfield, T., A.L. McGuire, M. Cho, J. A. Buchanan, M.M. Burgess, U. Danilczyk et al. 2008. Research ethics recommendations for whole-genome research: Consensus statement. PLOS Biology 6: 73
Caulfield, T., S. Burningham, Y. Joly, A. Master, M. Shabani et al. 2014. A review of the key issues associated with the commercialization of biobanks. Journal of Law and the Biosciences 1(1): 94–110.
CIHR. 2013. Updated guidelines for human pluripotent stem cell research. Retrieved 5 October, 2014 from http://www.cihr-irsc.gc.ca/e/42071.html.
CIHR. 2014. Stem Cell Oversight Committee. Retrieved 5 October, 2014 from http://www.cihr-irsc.gc.ca/e/19306.html. Accessed 5 Oct 2014
Clemence, M., N. Gilby, J. Shah, J. Swiecicka, D. Warren, P. Smith, J. Johnson, S. Nissen, F. Hoolahan, and J. d’Souza. 2013. Wellcome Trust Monitor Wave 2: Tracking Public Views on Science. London: Biomedical Research and Science Education.
Dickenson, D. 2007. Property in the body: Feminist perspectives. Cambridge: Cambridge University Press.
Government of Canada. (2010). Guidelines for human pluripotent stem cell research: National registry of human embryonic stem cell lines. Retrieved 5 October, 2014 from http://www.cihr-irsc.gc.ca/e/39580.html.
Haddow, G., G. Laurie, S. Cunningham-Burley, and K.G. Hunter. 2007. Tackling community concerns about commercialisation and genetic research: A modest interdisciplinary proposal. Social Science and Medicine 64: 272–282.
Hansson, M.G. 2009. Ethics and biobanks. British Journal of Cancer 100: 8–12.
Hansson, M.G., J. Dillner, C.R. Bartram, J.A. Carlson, and G. Helgesson. 2006. Should donors be allowed to give broad consent to future biobank research? Lancet Oncology 7: 266–269.
Homer, N., S. Szelinger, M. Redman, D. Duggan, W. Trembe, J. Meuhling,…D.W. Craig. 2008. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping micro-arrays. PLOS Genetics 4.
Kaufman, D.J., J. Murphy-Bollinger, J. Scott, and K.L. Hudson. 2009. Public opinion about the importance of privacy in biobank research. The American Journal of Human Genetics 85(5): 643–654.
Kaye, J. 2011. From single biobanks to international networks: developing e-governance. Human Genetics 130: 377–382.
Kaye, J., E.A. Whitley, N. Kanelloupoulou, S. Creese, S. Hughes, and D. Lund. 2011. Dynamic consent: A solution to a perennial problem? BMC 343: d6900.
Knoppers, B.M., M. Deschenes, M.H. Zawati, and A.M. Tasse. 2012. Population studies: Return of research results and incidental findings policy statement. European Journal of Human Genetics 21: 245–247.
Koenig, B.A. 2014. Have we asked too much of consent? Hastings Centre Report 44(4): 33–34.
Landy, D.C., M.A. Brinich, M.A. Colten, E.J. Horn, S.F. Terry, and R.R. Sharp. 2012. How disease advocacy organizations participate in clinical research: A survey of genetic organizations. Genetics in Medicine 14(2): 223–228.
Lowrance, W.W., and F.S. Collins. 2007. Identifiability in genomic research. Science 317: 600–602.
Luhmann, N. 2000. Familiarity, confidence, trust: Problems and alternatives. In Trust: Making and breaking cooperative relations, ed. D. Gambetta, 94–107. Oxford: Oxford University Press.
Lunshof, J.E., R. Chadwick, D.B. Vorhaus, and G.M. Church. 2008. From privacy to open consent. Nature Reviews Genetics 9(5): 406–411.
McGuire, A.L., and L.M. Beskow. 2010. Informed consent in genomics and genetic research. Annual Review of Genomics and Human Genetics 11: 361–381.
Mello, M.M., and L.E. Wolf. 2010. The Havasupai Indian Tribe case—Lessons for research involving stored biologic samples. New England Journal of Medicine 363: 204–207.
Mintrom, M., and R. Bollard. 2009. Governing controversial research Lessons from stem cell research. Policy and Society 28: 301–314.
Murphy, J., J. Scott, D. Kaufman, G. Geller, L. LeRoy, and K. Hudson. 2008. Public expectations for return of results from large-cohort genetic research. The American Journal of Bioethics 8(11): 36–43.
Murphy, J., M.S. Scott, D. Kaufman, G. Geller, L. LeRoy, and K. Hudson. 2009. Public perspectives on informed consent for biobanking. Health Policy and Ethics 99(12): 2128–2134.
O’Doherty, K., and M. Burgess. 2009. Engaging the public on biobanks: Outcomes of the BC Biobank Deliberation. Public Health Genomics 12(4): 203–215.
O’Doherty, K.C., and M.M. Burgess. 2013. Public deliberation to develop ethical norms and inform policy for biobanks: Lessons learnt and challenges remaining. Research Ethics 9(2): 55–77.
O’Doherty, K.C., M.M. Burgess, K. Edwards, R.P. Gallagher, A.K. Hawkins, J. Kaye, V. McCaffrey, and D.E. Winickoff. 2011. From consent to institutions: Designing adaptive governance for genomic biobanks. Social Science and Medicine 73: 367–374.
Ormond, K.E., A.L. Cirino, I.B. Helenowski, R.L. Chisholm, and W.A. Wolf. 2009. Assessing the understanding of biobank participants. American Journal of American Genetics A 149A(2): 188–198.
Parry, S. 2003. The politics of cloning: Mapping the rhetorical convergence of embryos and stem cells in parliamentary debates. New Genetics and Society 22(2): 177–200.
Parry, S. 2006. (Re)constructing embryos in stem cell research: Exploring the meaning of embryos for people involved in fertility treatments. Social Science and Medicine 62(10): 2349–2359.
Provoost, V., G. Pennings, P. De Sutter, J. Gerris, A. Van del Velde, and M. Dhont. 2010. Reflections by patients who undergo IVF on the use of their supernumerary embryos for science. Reproductive BioMedicine Online 20: 880–891.
Rothstein, M.A., and M.R. Anderlik. 2001. What is genetic discrimination, and when and how can it be prevented? Genetics and Medicine 3: 354–358.
Steinsbekk, K.S., B.K. Myskja, and B. Solberg. 2013. Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem? European Journal of Human Genetics 21: 897–902.
Stem Cell Network. 2009. What are Stem Cells. Retrieved 6 October, 2014 from http://www.stemcellnetwork.ca/index.php?page=what-are-stem-cells&hl=eng.
Thompson, C. 2014. Good science: The ethical choreography of stem cell research. Cambridge: MIT Press.
Waldby, C., and K. Carrol. 2012. Egg donation for stem cell research: Ideas of surplus and deficit in Australian IVF patients’ and reproductive donors’ accounts. Sociology of Health & Illness 34(4): 513–528.
Winickoff, D. 2009. From benefit sharing to power sharing: Partnership governance in population genomics research. In Principles and practice in biobank governance, ed. J. Kaye, and M. Stranger, 53–66. Farnham: Ashgate.
Wolf, S., Lawrenz, F., Nelson, C., Kahn, J., Cho, M., Wright-Clayton, E.,…Wilfond, B.S. 2008. Managing incidental findings in human subjects research: Analysis and recommendations. Journal of Law, Medicine & Ethics 36(2): 219–211.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stroud, K., O’Doherty, K.C. Ethically sustainable governance in the biobanking of eggs and embryos for research. Monash Bioeth. Rev. 33, 277–294 (2015). https://doi.org/10.1007/s40592-015-0047-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40592-015-0047-6